Blue Water Vaccines: Funding, Investors & Team (Aug 2026)
Blue Water Vaccines, Inc. is a biopharmaceutical company focused on developing transformational vaccines to address significant health challenges globally. Headquartered in Cincinnati, OH, the company holds the rights to proprietary technology developed at the University of Oxford, Cincinnati Children's Hospital Medical Center (CCHMC), and St. Jude Children's Hospital. The company is developing a universal flu vaccine that will provide protection from all virulent strains and a Streptococcus pneumoniae (pneumococcus) vaccine candidate, designed to specifically prevent the highly infectious middle ear infections, known as Acute Otitis Media (AOM), in children. Additionally, Blue Water Vaccines has licensed a novel norovirus (NoV) S&P nanoparticle versatile virus-like particle (VLP) vaccine platform from CCHMC to develop vaccines for multiple infectious diseases, including norovirus/rotavirus and malaria among others.
Blue Water Vaccines has raised $8.0M across 1 funding round on record, the most recent a Post-IPO Equity of $8.0M announced in Apr 2022.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Blue Water Vaccines Company Profile and Key Stats
Latest funding round on record: Apr 2022.
Blue Water Vaccines Funding Rounds
Blue Water Vaccines Founders and Leadership Team
Contact details for the Blue Water Vaccines team: 1 of 1 has an email address on file.
Start 14-day free trial →Blue Water Vaccines Funding Compared to Other Biotechnology Startups
Blue Water Vaccines' latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Blue Water Vaccines in Biotechnology and Cincinnati
Companies Similar to Blue Water Vaccines
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Blue Water Vaccines Funding FAQs
What does Blue Water Vaccines do?
Blue Water Vaccines, Inc. is a biopharmaceutical company focused on developing transformational vaccines to address significant health challenges globally. Headquartered in Cincinnati, OH, the company holds the rights to proprietary technology developed at the University of Oxford, Cincinnati Children's Hospital Medical Center (CCHMC), and St. Jude Children's Hospital. The company is developing a universal flu vaccine that will provide protection from all virulent strains and a Streptococcus pneumoniae (pneumococcus) vaccine candidate, designed to specifically prevent the highly infectious middle ear infections, known as Acute Otitis Media (AOM), in children. Additionally, Blue Water Vaccines has licensed a novel norovirus (NoV) S&P nanoparticle versatile virus-like particle (VLP) vaccine platform from CCHMC to develop vaccines for multiple infectious diseases, including norovirus/rotavirus and malaria among others.
How much funding has Blue Water Vaccines raised?
Blue Water Vaccines has raised $8.0M across 1 round on record. The most recent is a Post-IPO Equity of $8.0M announced in Apr 2022.
When did Blue Water Vaccines last raise funding?
Blue Water Vaccines' most recent funding round on record is a Post-IPO Equity of $8.0M, announced in Apr 2022.
Who is the CEO of Blue Water Vaccines?
Joseph Hernandez is listed as CEO at Blue Water Vaccines.
Where is Blue Water Vaccines headquartered?
Blue Water Vaccines is based in Cincinnati, Ohio, United States.
How many employees does Blue Water Vaccines have?
Blue Water Vaccines is in the 1-10 employee band.
How does Blue Water Vaccines' funding compare to other Biotechnology startups?
Blue Water Vaccines' latest round of $8.0M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Blue Water Vaccines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Blue Water Vaccines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.